Workflow
20cm速递|关注创业板医药ETF国泰(159377)投资机会,政策与业绩双驱动发展

Group 1 - The pharmaceutical and medical device industries are experiencing steady growth driven by policy support and technological innovation [1] - The State Council has approved the "Artificial Intelligence +" action plan, emphasizing the large-scale application of AI in healthcare, which will accelerate the commercialization of AI medical imaging and diagnostic assistance technologies [1] - The medical device sector is benefiting from the growth in healthcare demand and the localization of core components, with X-ray detection equipment being a key area of development [1] Group 2 - 3D printing technology is maturing in applications for medical implants and surgical models, with technological breakthroughs further expanding market opportunities [1] - The Guotai medical ETF (159377) tracks the innovative pharmaceutical index (399275), which can experience daily fluctuations of up to 20% [1] - The innovative pharmaceutical index focuses on companies with high R&D investment, innovation capabilities, and growth potential, reflecting the dynamics and trends in the biopharmaceutical industry [1]